ProShare Advisors LLC
- SEC CIK
- 0001357955
- Latest filing
- Aug 11, 2026
CTXR holding history
Citius Pharmaceuticals, Inc. in every 13F filed by ProShare Advisors LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
CTXR overviewAll 13F holders of CTXRFull Q2 2026 holdings
- Shares (Q3 2024)
- 0
- Sold out in Q3 2024
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 9
- Since Q2 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q3 2024 | 0 | $0 | 0.0% | −18,019−100.0% | Sold out | Holders |
| Q2 2024 | 18,019 | $10.5K | <0.1% | −6,150−25.4% | Reduced | Holders |
| Q1 2024 | 24,169 | $21.7K | <0.1% | +3,829+18.8% | Added | Holders |
| Q4 2023 | 20,340 | $15.4K | <0.1% | +4,375+27.4% | Added | Holders |
| Q3 2023 | 15,965 | $10.9K | <0.1% | −18−0.1% | Reduced | Holders |
| Q2 2023 | 15,983 | $19.2K | <0.1% | +15,983 | New | Holders |
| Q2 2022 | 0 | $0 | 0.0% | −23,231−100.0% | Sold out | Holders |
| Q1 2022 | 23,231 | $42.0K | <0.1% | −1,574−6.3% | Reduced | Holders |
| Q4 2021 | 24,805 | $38.0K | <0.1% | +10,255+70.5% | Added | Holders |
| Q3 2021 | 14,550 | $30.0K | <0.1% | −14,909−50.6% | Reduced | Holders |
| Q2 2021 | 29,459 | $103.0K | <0.1% | +29,459 | New | Holders |